Science Explorer Back to mapMap

Most cited papers from United Therapeutics (United States)

What are the most cited papers from United Therapeutics (United States)?

The most cited paper from United Therapeutics (United States) is "Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis" (Francis X. McCormack et al., 2011), with 1,131 citations. Next come "Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension" (831) and "Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays" (817).

Showing 50 of 60 papers. Every paper with more than 85 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis Francis X. McCormack et al. · New England Journal of Medicine Open access 16 Mar 2011 1,131
2 Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology Open access Apr 2002 831
3 Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays Raymond W. Tennant, Barry H. Margolin, Michael D. Shelby et al. · Science 22 May 1987 817
4 CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Jiehui Deng et al. · Cancer Discovery Open access 3 Nov 2017 801
5 A model for microwave emission from vegetation‐covered fields Tianxiao Mo, Bhaskar Jyoti Choudhury, Thomas J. Schmugge et al. · Journal of Geophysical Research Atmospheres 20 Dec 1982 750
6 Genetically Modified Porcine-to-Human Cardiac Xenotransplantation Bartley P. Griffith, Corbin E. Goerlich, Avneesh Kumar Singh et al. · New England Journal of Medicine Open access 22 Jun 2022 708
7 Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · New England Journal of Medicine Open access 13 Jan 2021 652
8 Beraprost therapy for pulmonary arterial hypertension Robyn J. Barst, Michael D. McGoon, Vallerie V. McLaughlin et al. · Journal of the American College of Cardiology Open access Jun 2003 634
9 A survey of interstellar molecular hydrogen. I Blair D. Savage, J. F. Drake, W. Budich et al. · The Astrophysical Journal Aug 1977 625
10 Effect of surface roughness on the microwave emission from soils Bhaskar Jyoti Choudhury, Thomas J. Schmugge, Alfred T. C. Chang et al. · Journal of Geophysical Research Atmospheres Open access 20 Sep 1979 624
11 The promise of organ and tissue preservation to transform medicine Sebastian Eriksson Giwa et al. · Nature Biotechnology Open access Jun 2017 552
12 Results of Two Cases of Pig-to-Human Kidney Xenotransplantation Robert A. Montgomery et al. · New England Journal of Medicine Open access 18 May 2022 501
13 Remote sensing of soil moisture content, over bare field at 1.4 GHz frequency J. R. Wang, Bhaskar Jyoti Choudhury · Journal of Geophysical Research Atmospheres 20 Jun 1981 487
14 Observational, reference and model data on solar EUV, from measurements on AE‐E Hans E. Hinteregger, Katsura Fukui, Bruce R. Gilson · Geophysical Research Letters Nov 1981 463
15 Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study) Victor F. Tapson, Fernando Torres, Fiona D. Kermeen et al. · CHEST Journal 25 May 2012 379
16 Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil R. J. Barst, Nazzareno Galiè, Robert Naeije et al. · European Respiratory Journal Open access 9 Aug 2006 336
17 Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension Zhi‐Cheng Jing, Keyur H. Parikh, Tomás Pulido et al. · Circulation 11 Jan 2013 326
18 Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) Victor F. Tapson, Zhi‐Cheng Jing, Kai‐Feng Xu et al. · CHEST Journal 17 May 2013 298
19 The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study Blake M. Paterson, Karen Manon Lammers, Marie‐Claire Arrieta et al. · Alimentary Pharmacology & Therapeutics Open access 19 Jun 2007 283
20 The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension Stephen C. Mathai, Milo Alan Puhan, Diana L. Lam et al. · American Journal of Respiratory and Critical Care Medicine Open access 22 Jun 2012 277
21 Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension Vallerie V. McLaughlin, Seán Gaine, Robyn J. Barst et al. · Journal of Cardiovascular Pharmacology Feb 2003 233
22 A parameterization of effective soil temperature for microwave emission Bhaskar Jyoti Choudhury, Thomas J. Schmugge, Tianxiao Mo · Journal of Geophysical Research Atmospheres Open access 20 Feb 1982 215
23 Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension Dinesh Khanna, Heather S. Gladue, Richard N. Channick et al. · Arthritis & Rheumatism Open access 11 Sep 2013 212
24 Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study Ciarán P. Kelly, P. H. R. Green, Joseph A. Murray et al. · Alimentary Pharmacology & Therapeutics 19 Nov 2012 204
25 Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial Jagdish Hiremath, S Thanikachalam, Keyur H. Parikh et al. · The Journal of Heart and Lung Transplantation Open access 18 Dec 2009 199
26 Randomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian Cancer Jonathan S. Berek, Peyton T. Taylor, Alan N. Gordon et al. · Journal of Clinical Oncology Open access 30 Aug 2004 196
27 Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers Kevin Laliberte, Carl P. Arneson, Roger Jeffs et al. · Journal of Cardiovascular Pharmacology 8 Jul 2004 184
28 Dry Powder Inhalers: An Overview Paul J. Atkins · Respiratory Care Oct 2005 182
29 Justification of specific genetic modifications in pigs for clinical organ xenotransplantation David K. C. Cooper, Hidetaka Hara, Hayato Iwase et al. · Xenotransplantation Open access 15 Apr 2019 181
30 Pig-to-human heart xenotransplantation in two recently deceased human recipients Nader Moazami et al. · Nature Medicine 24 Jul 2023 179
31 A Randomized, Double-Blind, Multicenter Comparison of the Efficacy and Tolerability of Restylane Versus Zyplast for the Correction of Nasolabial Folds Rhoda S. Narins, Fredric S Brandt, JAMES LEYDEN et al. · Dermatologic Surgery Jun 2003 178
32 Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19 Zhenhua Li, Zhenzhen Wang, Phuong‐Uyen Dinh et al. · Nature Nanotechnology Open access 17 Jun 2021 178
33 A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG) Mercedeh Ghadessi, Rui Sammi Tang, Joey Tianyi Zhou et al. · Orphanet Journal of Rare Diseases Open access 12 Mar 2020 177
34 Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer Jonathan S. Berek, Peyton T. Taylor, William Patrick McGuire et al. · Journal of Clinical Oncology 16 Dec 2008 172
35 Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer Craig M. Goodwin et al. · Cancer Research Open access 8 Nov 2022 171
36 Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist Brendan J.R. Whittle, Adam M. Silverstein, David M. Mottola et al. · Biochemical Pharmacology Open access 27 Mar 2012 168
37 Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension Alan L. Hinderliter, Park W. Willis, Walker A. Long et al. · The American Journal of Cardiology Aug 1999 164
38 Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial R. James White, Carlos Jerjes‐Sánchez, Gisela Martina Bohns Meyer et al. · American Journal of Respiratory and Critical Care Medicine Open access 25 Nov 2019 156
39 Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study Steven D. Nathan, Aaron B. Waxman, Sudarshan Rajagopal et al. · The Lancet Respiratory Medicine 29 Jun 2021 148
40 A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder John H. Greist, James W. Jefferson, Kenneth A. Kobak et al. · International Clinical Psychopharmacology Jun 1995 135
41 Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits Bryan C. Quach et al. · Nature Communications Open access 3 Nov 2020 133
42 Initial scalar magnetic anomaly map from MAGSAT R. A. Langel, Jeffrey D. Phillips, R. J. Horner · Geophysical Research Letters Apr 1982 129
43 Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression John Bisi, Jessica A. Sorrentino, Patrick J. Roberts et al. · Molecular Cancer Therapeutics 29 Jan 2016 127
44 Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1) Toufike Kanouni, Christophe Severin, Robert W. Cho et al. · Journal of Medicinal Chemistry Open access 9 Oct 2020 126
45 Transitioning From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension Jean‐Luc Vachiéry, Nicholas S. Hill, Diane L. Zwicke et al. · CHEST Journal May 2002 125
46 Lactate Dehydrogenase and the Diagnosis of Malaria Michael T. Makler, Robert C. Piper, Wilbur K. Milhous · Parasitology Today Sep 1998 112
47 Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials Raymond L. Benza, Mardi Gomberg‐Maitland, Robert Naeije et al. · The Journal of Heart and Lung Transplantation 6 May 2011 105
48 PC-BEIS: A Personal Computer Version of the Biogenic Emissions Inventory System Thomas E. Pierce, Paul S. Waldruff · Journal of the Air & Waste Management Association Open access Jul 1991 102
49 Transplantation of a genetically modified porcine heart into a live human Bartley P. Griffith et al. · Nature Medicine 8 Jan 2025 99
50 A Golgi-targeting fluorescent probe for labile Fe( ii ) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35 Tasuku Hirayama, Masatoshi Inden, Hitomi Tsuboi et al. · Chemical Science Open access 25 Nov 2018 96

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.